Abbott India Limited

27,351.199

INR
-278.60(-1.01%)
As of November 14, 2024 10:00:00 AM

Abbott India Limited Share Price Information

24 hour Low and High

Low: 27255
High: 27887.65

All time High

30195.85

Price Change 1h

+₹-536.45 +-1.92%

Price Change 1d

+₹-536.45 +-1.92%

Price Change 1w

+₹-1201.85 +-4.21%

Abbott India Limited Market Information

Exchange

NSE

Market Cap

60422.33 Cr

About Abbott India Limited Share

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Sector

Healthcare

Drug Manufacturers - General

Employees

about

3814

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
  • Abbott India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Rs 410 dividend pharma stock to trade ex-date on Friday, July 19 - Do you own?
  • Abbot India signs non-exclusive patent license agreement to market Vonoprazan under the brand name Vonefi
  • Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

FAQs

Abbott India Limited

27,351.199

INR
-278.60(-1.01%)
As of November 14, 2024 10:00:00 AM

Abbott India Limited Share Price Information

24 hour Low and High

Low: 27255
High: 27887.65

All time High

30195.85

Price Change 1h

+₹-536.45 +-1.92%

Price Change 1d

+₹-536.45 +-1.92%

Price Change 1w

+₹-1201.85 +-4.21%

Abbott India Limited Market Information

Exchange

NSE

Market Cap

60422.33 Cr

About Abbott India Limited Share

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Sector

Healthcare

Drug Manufacturers - General

Employees

about

3814

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
  • Abbott India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Rs 410 dividend pharma stock to trade ex-date on Friday, July 19 - Do you own?
  • Abbot India signs non-exclusive patent license agreement to market Vonoprazan under the brand name Vonefi
  • Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

FAQs